{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:49:47Z","timestamp":1787316587532,"version":"build-2736575974"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["15650501"],"award-info":[{"award-number":["15650501"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007235","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T13:25:32Z","timestamp":1553520332000},"page":"e0007235","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Oral activity of the antimalarial endoperoxide 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) against Leishmania donovani complex"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0133-9471","authenticated-orcid":true,"given":"Kofi Dadzie","family":"Kwofie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizu","family":"Sanjoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akina","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Shimogawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Amoa-Bosompem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Boakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham K.","family":"Anang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Soo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4394-7267","authenticated-orcid":true,"given":"Shiroh","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"ref1","unstructured":"WHO. Visceral Leishmaniasis [Internet]. Programmes, Epidemiology. 2018 [cited 2018 Jan 17]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/leishmaniasis\/burden\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/leishmaniasis\/burden\/en\/<\/ext-link>"},{"issue":"22","key":"ref2","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"IL Mauricio","year":"2007","journal-title":"PNAS"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004349","article-title":"A Historical Overview of the Classification, Evolution, Dispersion of Leishmania Parasites Sflies","volume":"10","author":"M Akhoundi","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"22","key":"ref4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa021556","article-title":"Oral Miltefosine for Indian visceral Leishmaniasis","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"issue":"24","key":"ref5","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"TK Jha","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"ref6","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management","volume":"3","author":"S Sundar","year":"2007","journal-title":"Ther Clin Risk Manag"},{"issue":"1740\u20131534 (Electronic)","key":"ref7","first-page":"873","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment control?","volume":"5","author":"F Chappuis","year":"2007","journal-title":"NatRevMicrobiol"},{"issue":"March","key":"ref8","first-page":"22","article-title":"Control of the Leishmaniases","volume":"949","year":"2010","journal-title":"Tech Rep Ser"},{"key":"ref9","article-title":"Leishmaniasis: an update of current pharmacotherapy","author":"S Sundar","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"11\u201312","key":"ref10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.drudis.2007.04.009","article-title":"New developments in synthetic peroxidic drugs as artemisinin mimics","volume":"12","author":"CW Jefford","year":"2007","journal-title":"Drug Discov Today"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm030571c","article-title":"A medicinal chemistry perspective on artemisinin related endoperoxides","volume":"47","author":"PM O\u2019Neill","year":"2004","journal-title":"J Med Chem"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1099\/jmm.0.47364-0","article-title":"Artemisinin triggers induction of cell-cycle arrest apoptosis in Leishmania donovani promastigotes","volume":"56","author":"R Sen","year":"2007","journal-title":"J Med Microbiol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijantimicag.2010.03.008","article-title":"Efficacy of artemisinin in experimental visceral leishmaniasis","volume":"36","author":"R Sen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5455\/2319-2003.ijbcp20140815","article-title":"Evaluation of anti-leishmanial activity of artemisinin combined with amphotericin B or miltefosine in Leishmania donovani promastigotes","volume":"3","author":"M Rahaman","year":"2014","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"2","key":"ref15","first-page":"258","article-title":"Evaluation of Apoptotic Antileishmanial Activities of Artemisinin on Promastigotes BALB\/C Mice Infected with Leishmania major","volume":"10","author":"F Ghaffarifar","year":"2015","journal-title":"Iran J Parasitol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2147\/IJN.S106548","article-title":"Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis","volume":"12","author":"MY Want","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15806\/j.issn.2311-8571.2016.0002","article-title":"Exping the Therapeutic Spectrum of Artemisinin: Activity Against Infectious Diseases Beyond Malaria Novel Pharmaceutical Developments","volume":"2","author":"T, R. Efferth","year":"2016","journal-title":"World J Tradit Chinese Med"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3109\/10715762.2010.498475","article-title":"Iron enhances generation of free radicals by Artemisinin causing a caspase-independent, apoptotic death in Leishmania donovani promastigotes","volume":"44","author":"R Sen","year":"2010","journal-title":"Free Radic Res"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1462-5822.2008.01241.x","article-title":"Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth","volume":"11","author":"NK Das","year":"2009","journal-title":"Cell Microbiol"},{"issue":"14","key":"ref20","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1021\/jm010026g","article-title":"Synthesis Antimalarial Activity of Novel Medium-Sized 1,2,4,5-Tetraoxacycloalkanes","volume":"44","author":"H-S Kim","year":"2001","journal-title":"J Med Chem"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.parint.2011.04.001","article-title":"Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol","volume":"60","author":"A Sato","year":"2011","journal-title":"Parasitol Int"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parint.2016.06.013","article-title":"In vitro inhibition of Toxoplasma gondii by the anti-malarial cidate, 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol","volume":"65","author":"CF Xin","year":"2016","journal-title":"Parasitol Int"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.parint.2011.02.007","article-title":"Schistosomicidal antifecundity effects of oral treatment of synthetic endoperoxide N-89","volume":"60","author":"T Taniguchi","year":"2011","journal-title":"Parasitol Int"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.parint.2016.10.013","article-title":"Novel synthetic compounds with endoperoxide structure damage juvenile stage of Schistosoma mansoni by targeting lysosome-like organelles","volume":"66","author":"M Yamabe","year":"2017","journal-title":"Parasitol Int"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.parint.2018.03.006","article-title":"Insights into the mode of action of 1,2,6,7-tetraoxaspiro [7.11] nonadecane (N-89) against adult Schistosoma mansoni worms","volume":"67","author":"EA Blay","year":"2018","journal-title":"Parasitol Int"},{"issue":"November 2017","key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrep.2018.05.007","article-title":"Multiple antiviral activities of the antimalarial anti-hepatitis C drug cidates N-89 N-251","volume":"15","author":"Y Ueda","year":"2018","journal-title":"Biochem Biophys Reports"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0072519","article-title":"New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication","volume":"8","author":"Y Ueda","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref28","article-title":"Host Resistance to the Khartoum Strain of Leishmania donovani","volume":"45","author":"LA Stauber","year":"1958","journal-title":"Rice Inst Pam Rice Univ Stud"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/600105","article-title":"Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis","volume":"200","author":"KM Wasan","year":"2009","journal-title":"J Inifectious Dis"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.apjtm.2017.09.001","article-title":"A new approach for development of vaccine against visceral leishmaniasis: Lipophosphoglycan polyacrylic acid conjugates","volume":"10","author":"AM Allahverdiyev","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"S Wyllie","year":"2018","journal-title":"Nature"},{"issue":"January","key":"ref32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpddr.2018.01.006","article-title":"IJP: Drugs Drug Resistance In vitro in vivo pharmacodynamics of three novel antileishmanial lead series","volume":"8","author":"M Van Den Kerkhof","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"e1629","DOI":"10.1371\/journal.pntd.0001629","article-title":"Evaluation of Nephroprotective Immunomodulatory Activities of Antioxidants in Combination with Cisplatin against Murine Visceral Leishmaniasis","volume":"6","author":"M Sharma","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00436-007-0464-4","article-title":"Characterization of Leishmania isolates from Nepalese patients with visceral leishmaniasis","volume":"100","author":"K Pey","year":"2007","journal-title":"Parasitol Res"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004505","article-title":"Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani","volume":"10","author":"A Morimoto","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"ref36","first-page":"165","article-title":"Establishment of an appropriate inoculum dose of Leishmania donovani promastigotes required to establish a visceral infection in laboratory animal rodent models","volume":"1","author":"PA Mbati","year":"1994","journal-title":"Afr J Health Sci"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4269\/ajtmh.13-0376","article-title":"BOne marrow parasite burden among patients with new world kala-azar is associated with disease severity","volume":"90","author":"JM Silva","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"ref38","first-page":"222","article-title":"Pathologic changes in murine leishmaniasis (Leishmania donovani) with special reference to the dynamics of granuloma formation in the liver","volume":"114","author":"Y Gutierrez","year":"1984","journal-title":"Am J Pathol"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","article-title":"New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment","volume":"48","author":"MA Ch\u00e1vez-Fumagalli","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention control of drug resistance","volume":"6","author":"A Bryceson","year":"2001","journal-title":"Trop Med Int Heal"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2329-891X.1000203","article-title":"Miltefosine Susceptibility Resistance in Leishmania: From the Laboratory to the Field","volume":"04","author":"AC Coelho","year":"2016","journal-title":"J Trop Dis"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2613.2001.00199.x","article-title":"Tissue granuloma structure-function in experimental visceral leishmaniasis","volume":"82","author":"HW Murray","year":"2001","journal-title":"Int J Exp Pathol"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Mcelrath MJ, Murray HW, Cohn ZA. THE DYNAMICS OF GRANULOMA FORMATION IN EXPERIMENTAL VISCERAL LEISHMANIASIS BY Leishmania donovani is an intracellular parasite that infects parenchymal macro- phages of susceptible animals (1). Unlike infection with L. major (2) or L. mexicana (3. 1988;167(June).","DOI":"10.1084\/jem.167.6.1927"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/dkt486","article-title":"Rapid kill of malaria parasites by artemisinin semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential","volume":"69","author":"T Antoine","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"May 1999","key":"ref45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-6147(99)01302-4","article-title":"Artemisinin drugs in the treatment of malaria: from medicinal herb to registered med- ication","volume":"20","author":"MA van Agtmael","year":"1999","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1021\/pr3005315","article-title":"Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, n-89 N-251","volume":"11","author":"M Morita","year":"2012","journal-title":"J Proteome Res"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.parint.2011.08.017","article-title":"Antimalarial activity of 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) its carboxylic acid derivatives","volume":"60","author":"A Sato","year":"2011","journal-title":"Parasitol Int"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/bj20021684","article-title":"Role of superoxide dismutase in survival of Leishmania within the macrophage","volume":"369","author":"S GHOSH","year":"2003","journal-title":"Biochem J"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tim.2007.01.001","article-title":"Intracellular Leishmania: your iron or mine?","volume":"15","author":"JF Marquis","year":"2007","journal-title":"Trends Microbiol"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/AAC.01574-13","article-title":"Elucidation of cellular mechanisms involved in experimental paromomycin resistance in leishmania donoVani","volume":"58","author":"V Bhari","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpddr.2016.12.004","article-title":"In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruzi","volume":"7","author":"A Botero","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1007\/s00436-016-5195-y","article-title":"Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance","volume":"115","author":"MCN Laffitte","year":"2016","journal-title":"Parasitol Res"},{"issue":"9","key":"ref53","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities challenges in antiparasitic drug discovery","volume":"4","author":"R Pink","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0001463","article-title":"Genetic polymorphisms drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan","volume":"6","author":"M Plourde","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.parint.2016.10.013","article-title":"Novel synthetic compounds with endoperoxide structure damage juvenile stage of Schistosoma mansoni by targeting lysosome-like organelles","volume":"66","author":"M Yamabe","year":"2017","journal-title":"Parasitol Int"},{"issue":"3","key":"ref56","first-page":"185","article-title":"Drugs Drug Resistance Repurposing drugs for the treatment control of helminth infections","volume":"4","author":"G Panic","year":"2014","journal-title":"Int J Parasitol"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"Ivermectin, \u2018Wonder drug\u2019 from Japan: the human use perspective","volume":"87","author":"A CRUMP","year":"2011","journal-title":"Proc Japan Acad Ser B"},{"issue":"1","key":"ref58","first-page":"1","article-title":"Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function the Activation of the Sphingosine-Dependent Plasma Membrane","volume":"62","author":"AK Pinto-Martinez","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"02","key":"ref59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2329-891X.1000203","article-title":"Miltefosine Susceptibility Resistance in Leishmania: From the Laboratory to the Field","volume":"04","author":"AC Coelho","year":"2016","journal-title":"J Trop Dis"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of kala-azar in nepal the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"S Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"Leishmania resistance to miltefosine associated with genetic marker","volume":"18","author":"S Cojean","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"ref62","first-page":"1","article-title":"Drug susceptibility in Leishmania isolates following Miltefosine treatment in cases of Visceral Leishmaniasis post Kala-Azar dermal Leishmaniasis","volume":"6","author":"V Bhari","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"9430","key":"ref63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(04)16680-4","article-title":"Antimalarial combinations","volume":"364","author":"PG Kremsner","year":"2004","journal-title":"Lancet"},{"key":"ref64","unstructured":"WHO. Research Priorities for Chagas Disease, Human African Trypanosomiasis Leishmaniasis. Tech Rep TDR Dis Ref Gr Chagas Dis Hum Trypanomiasis Leishmaniasis [Internet]. 2012;100. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tdr\/publications\/research_priorities\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tdr\/publications\/research_priorities\/en\/<\/ext-link>"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"J van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000818","article-title":"Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent","volume":"4","author":"F Meheus","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref67","first-page":"555","article-title":"Treatment options for visceral leishmaniasis","volume":"9","author":"M den Boer","year":"2011","journal-title":"Expert Rev Anti Inect Ther"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:46:26Z","timestamp":1588999586000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007235"}},"subtitle":[],"editor":[{"given":"Laura-Isobel","family":"McCall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007235","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,25]]}}}